Who owns the brand “stem cells” ?
Lofty scientific societies, such as the International Society for Stem Cell Research (ISSCR)? How about medical associations like the American Society for Plastic Surgeons (ASPS) or members of the International Federation for Adipose Therapeutics and Science (IFATS)? Or perhaps the term “stem cells” is generic- to be utilized by any local health care professional, with no particular training?
This is a very hot topic right now. The FDA is calling out alleged “bad actors” and there have been a number of notorious medical malpractice cases filed around the country. But hundreds of practitioners are bringing lawful cell therapies into their practice with safe outcomes, most without verification.
What’s a doctor or patient to do?
I say get smart – learn what’s “kosher” and what is problematic. If you want to learn something this month, then attend the Regenerative Medicine in the Clinic track at World Stem Cell Summit & Phacilitate Leaders World, January 22-25 at the Hyatt Regency Miami. CME credits available.
We also have sessions that get right to the point.
BRINGING ORDER TO THE WILD WEST! REGULATORY ENFORCEMENT, LAWSUITS AND ETHICAL CONSIDERATIONS FOR STEM CELLS IN CLINICAL PRACTICE
NEED TO KNOW! LEGAL AND REGULATORY ISSUES IMPACTING CLINICIANS